Viking lifts ICP Bio stake

Listed investment company Viking Capital has lifted its stake in ICP Biotechnology to 17.5 per cent.

This week Viking said it had bought an 11.5 per cent stake in ICP for $1.75 million cash, plus Viking shares.

It asked for a trading halt Tuesday and announced it had bought another 6 per cent of ICP from a different party in return for $1.27 million in Viking shares.

ICP manufactures and sells products related to animal health, veterinary and human pharmaceuticals.